Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MRVL

Go back to Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers
(NASDAQ: HURA) Delayed: 2.32 +0.13 (5.94%)
Previous Close $2.19    52 Week High $ 
Open $2.20    52 Week Low $ 
Day High $2.35    P/E N/A 
Day Low $2.18    EPS $ 
Volume 436,721       

(NASDAQ: KTRA) Delayed: 0.22 --0 (-0%)
Previous Close $0.22    52 Week High $ 
Open $0.22    52 Week Low $ 
Day High $0.22    P/E N/A 
Day Low $0.22    EPS $ 
Volume 693,306       

(NASDAQ: LEGN) Delayed: 35.87 -0.41 (1.13%)
Previous Close $36.28    52 Week High $ 
Open $36.22    52 Week Low $ 
Day High $36.85    P/E N/A 
Day Low $34.88    EPS $ 
Volume 1,700,479